Clinical Trials Sponsored by Xiansheng Pharmaceutical Company

Total 512 results

Mutual Pharmaceutical Company, Inc.

Completed

A Dose Proportionality Study of Quinine Sulfate Capsules Under Fasting Conditions

Healthy
Mutual Pharmaceutical Company, Inc.

Completed

A Pharmacokinetic Study of Colchicine With an Oral Contraceptive

Pharmacokinetics

United States
Mutual Pharmaceutical Company, Inc.

Completed

Fasted Bioavailability Study of Cilostazol Tablets, 100 mg

Therapeutic Equivalency
Mutual Pharmaceutical Company, Inc.

Completed

Bioequivalence Study of Colchicine Tablets

Healthy

United States
Mutual Pharmaceutical Company, Inc.

Completed

Pharmacokinetic and Exploratory Electrocardiogram (ECG) Study

Pharmacokinetics

United States
Mutual Pharmaceutical Company, Inc.

Completed

Drug-Drug Interaction Study of Colchicine and Azithromycin

Pharmacokinetics
Mutual Pharmaceutical Company, Inc.

Completed

Drug - Drug Interaction Study Between Quinine Sulfate and Theophylline

Pharmacokinetics

United States
Mutual Pharmaceutical Company, Inc.

Completed

Drug-Drug Interaction Study Between Colchicine and Diltiazem ER

Healthy; Adult; Volunteer; Colchicine; Pharmacokinetics; Diltiazem; Cytochrome p450 3A4; P-glycoprotein

United States
Mutual Pharmaceutical Company, Inc.

Completed

Drug-Drug Interaction Between Colchicine and Ritonavir

Pharmacokinetics

United States
Hanmi Pharmaceutical Company Limited

Completed

Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension

Hypertension

Korea, Republic of
La Jolla Pharmaceutical Company

Terminated

Study of LJP 394 in Lupus Patients With History of Renal Disease (ASPEN)

Lupus Erythematosus, Systemic | Lupus Nephritis

Taiwan, United States, Belarus, Serbia, Czech Republic, Philippines, Lebanon, India, Korea, Republic of, Argentina, Australia, Brazil, Bulgaria, Georgia, Germany, Hong Kong, Hungary, Indonesia, Italy, Malaysia, Mexico, Poland, Portugal and more
La Jolla Pharmaceutical Company

Completed

Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

Autoimmune Diseases | Systemic Lupus Erythematosus | Lupus Nephritis | Immunologic Diseases | Lupus Glomerulonephritis

United States, Austria, Canada, France, Germany, Italy, Mexico, Spain, Sweden, United Kingdom
Tetraphase Pharmaceuticals, Inc.
PRA Health Sciences

Completed

Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers (BAL)

Healthy Subjects

United Kingdom
Darnitsa Pharmaceutical Company
International Pharmaceutical Research Center

Completed

Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Jordan
Darnitsa Pharmaceutical Company
International Pharmaceutical Research Center

Completed

Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide Film-coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Jordan
POLYSAN Scientific & Technological Pharmaceutical...

Recruiting

Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis

Cholestasis, Intrahepatic

Russian Federation
Sichuan Enray Pharmaceutical Sciences Company

Recruiting

Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor (CNSI-Fe(II))

Cervical Cancer | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Advanced Solid Tumor | Pancreas Cancer | Thyroid Cancer | Vulva Cancer

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Completed

The Mass Balance Study of LP-168 in Healthy Subjects

Clinical Pharmacology

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Active, not recruiting

A Study of LP-128 Capsules in Healthy Subjects

Chronic Hepatitis b

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Completed

A Food Effect Study of LP-168 Tablets in Healthy Subjects

Mantle Cell Lymphoma

China
POLYSAN Scientific & Technological Pharmaceutical...

Completed

Cytoflavin in Combination With Reperfusion in Stroke Patients

Acute Stroke

Russian Federation
Guangzhou Lupeng Pharmaceutical Company LTD.

Completed

A Study of LP-168 in Healthy Volunteers

Multiple Sclerosis | NMO Spectrum Disorder

China
POLYSAN Scientific & Technological Pharmaceutical...

Completed

Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy (CYLINDER)

Diabetic Neuropathies

Russian Federation
POLYSAN Scientific & Technological Pharmaceutical...

Completed

Cytoflavin in the Rehabilitation of Post-intensive Care Syndrome in Stroke Survivors

Ischemic Stroke | Post Intensive Care Unit Syndrome

Russian Federation
Sanofi
Hanmi Pharmaceutical Company Limited

Terminated

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea (AMPLITUDE-S)

Type 2 Diabetes Mellitus

United States, China, Taiwan
POLYSAN Scientific & Technological Pharmaceutical...

Completed

Remaxol® in Mechanical Jaundice of Non-malignant Origin

Jaundice, Obstructive

Russian Federation
POLYSAN Scientific & Technological Pharmaceutical...

Completed

"Unifuzol®" in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Russian Federation
VanWorld Pharmaceutical (Rugao) Company Limited

Completed

Analgecine for the Treatment of Neuropathic Pain

Neuropathic Pain
Guangzhou Lupeng Pharmaceutical Company LTD.

Recruiting

Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma

B-cell Non-Hodgkin Lymphoma

China
POLYSAN Scientific & Technological Pharmaceutical...

Recruiting

Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza

Influenza | Acute Respiratory Infection

Russian Federation
POLYSAN Scientific & Technological Pharmaceutical...

Recruiting

Remaxol® in Patients With Drug-induced Liver Injuries During Cancer Chemotherapy

Cancer | Drug Induced Liver Injury

Russian Federation
Guangzhou Lupeng Pharmaceutical Company LTD.

Recruiting

A Study of LP-168 in Participants With Relapse or Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma (MCL)

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Recruiting

A Study of LP-118 in Patients With Advanced Tumors

Lymphoma, Non-Hodgkin | Solid Tumor

China
POLYSAN Scientific & Technological Pharmaceutical...

Recruiting

International Trial of Efficacy of Cytoflavin in Head Trauma (MITRA)

Head Trauma,Closed

Russian Federation
COUR Pharmaceutical Development Company, Inc.

Active, not recruiting

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

Primary Biliary Cholangitis

United States
Mochida Pharmaceutical Company, Ltd.
Pfizer

Completed

A Study of MD-120 in Patients With Depression

Major Depressive Disorder

Japan
POLYSAN Scientific & Technological Pharmaceutical...

Completed

Correction of Metabolic Disorders and Its Effect on Respiratory Function of Lungs in Patients With Severe COVID-19 (CARECOVID)

COVID-19

Russian Federation
Hanmi Pharmaceutical Company Limited
Sanofi

Completed

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise (AMPLITUDE-M)

Type 2 Diabetes Mellitus

United States, Germany, Poland, Ukraine, United Kingdom
Sanofi
Hanmi Pharmaceutical Company Limited

Terminated

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s) (AMPLITUDE-L)

Type 2 Diabetes Mellitus

Korea, Republic of, United States, China
Sanofi
Hanmi Pharmaceutical Company Limited

Terminated

Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin (AMPLITUDE-D)

Type 2 Diabetes Mellitus

United States, Poland, Ukraine, Hungary
Sanofi
Hanmi Pharmaceutical Company Limited

Terminated

Effect of Efpeglenatide on Cardiovascular Outcomes (AMPLITUDE-O)

Type 2 Diabetes Mellitus

Estonia, Spain, Ukraine, Italy, Germany, Canada, Mexico, United States, Argentina, Bulgaria, Chile, Denmark, Finland, Hungary, India, Korea, Republic of, Latvia, Lithuania, Norway, Peru, Poland, Romania, Russian Federation, Serbia, Slov... and more
POLYSAN Scientific & Technological Pharmaceutical...

Completed

Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers

Peripheral Vascular Disease

Russian Federation
POLYSAN Scientific & Technological Pharmaceutical...

Completed

Remaxol® in Malignant Mechanical Jaundice

Jaundice; Malignant

Russian Federation
VanWorld Pharmaceutical (Rugao) Company Limited

Completed

Analgecine for Treatment of Low Back Pain

Low Back Pain

China
COUR Pharmaceutical Development Company, Inc.

Not yet recruiting

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

Myasthenia Gravis | Generalized Myasthenia | AChR Myasthenia Gravis | MuSK MG

United States
POLYSAN Scientific & Technological Pharmaceutical...

Recruiting

Cytoflavin in the Complex Rehabilitation of Stroke Patients

Stroke

Russian Federation
POLYSAN Scientific & Technological Pharmaceutical...

Recruiting

Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice

Obstructive Jaundice | Gallstone Disease

Russian Federation
POLYSAN Scientific & Technological Pharmaceutical...

Recruiting

Study of Safety and Efficiency of the Drug Reamberin® in the Intensive Care of Patients With Acute Ethanol Intoxication

Ethanol Intoxication

Russian Federation
Guangzhou Lupeng Pharmaceutical Company LTD.

Recruiting

A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Recruiting

A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma

B-cell Lymphoma

China

Clinical Trials Sponsored by Xiansheng Pharmaceutical Company

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations